Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-12-25
2007-12-25
Desai, Rita (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C544S111000, C548S517000, C514S318000, C514S326000
Reexamination Certificate
active
10730265
ABSTRACT:
Compounds of general formula (I)are disclosed and claimed in the present application, as well as their pharmaceutically acceptable salts, pharmaceutical compositions comprising the novel compounds and their use in therapy, in particular in the management of pain.
REFERENCES:
patent: 2898339 (1959-08-01), Wheeler et al.
patent: 4581171 (1986-04-01), Kennis et al.
patent: 4816586 (1989-03-01), Portoghese
patent: 4939137 (1990-07-01), Russell et al.
patent: 5140029 (1992-08-01), Kennis et al.
patent: 5574159 (1996-11-01), Chang et al.
patent: 5683998 (1997-11-01), Shibayama et al.
patent: 6187792 (2001-02-01), Delorme et al.
patent: 6455545 (2002-09-01), Delorme et al.
patent: 6693117 (2004-02-01), Delorme et al.
patent: WO 93/15062 (1993-08-01), None
patent: WO 97/23466 (1997-07-01), None
patent: WO 98/28275 (1998-07-01), None
patent: WO 99/33806 (1999-07-01), None
patent: WO 01/74804 (2001-10-01), None
patent: WO 01/74806 (2001-10-01), None
Barber, et al., “Antinociceptive Effects of the 5-HT2Antagonist Ritanserin in Rats: Evidence for an Activation of Descending Monoaminergic Pathways in the Spinal Cord,”Neurosci. Letters 99:234-238 (1989).
Bilsky, et al., “SNC 80, a Selective, Nonpeptidic and Systemically Active OpioidDeltaAgonist,”J. Pharmacol. Experi. Ther. 273:359-366 (1995).
Greene, “Protective Groups in Organic Synthesis,” Wiley & Sons, pp. 218, 220, 232, 233, 251 (1982).
Takemori, et al., “Selective Natrexone-Derived Opioid Receptor Antagonists,”Annu. Ref. Pharmacol. Toxicol. 32:239-269 (1992).
Wei, et al., “N,N-Diethyl-4-(phenylpiperidin-4-ylidenemethyl)benzamide: A Novel, Exceptionally Selective, Potent δ Opioid Receptor Agonist with Oral Bioavailability and Its Analogues,”J. Med. Chem. 43:3895-3905 (2000).
Zhang, et al., “Probes for Narcotic Receptor Mediated Phenomena. 26.1-3Synthesis and Biological Evaluation of Diarylmethylpiperazines and Diarylmethylpiperidines as Novel, Nonpeptidic δ Opioid Receptor Ligands,”J. Med. Chem. 42:5455-5463 (1999).
Delorme Daniel
Roberts Edward
Wei Zhong-yong
AstraZeneca Canada Inc.
Cohen Jacqueline M.
Desai Rita
LandOfFree
Compounds with analgesic effect does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds with analgesic effect, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds with analgesic effect will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3871444